- Home
- MVF vs SGMO Comparison
MVF vs SGMO Comparison
Compare MVF & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVF
- SGMO
- Stock Information
- Founded
- MVF 1988
- SGMO 1995
- Country
- MVF United States
- SGMO United States
- Employees
- MVF N/A
- SGMO N/A
- Industry
- MVF Investment Bankers/Brokers/Service
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVF Finance
- SGMO Health Care
- Exchange
- MVF Nasdaq
- SGMO Nasdaq
- Market Cap
- MVF 465.2M
- SGMO 488.2M
- IPO Year
- MVF N/A
- SGMO 2000
- Fundamental
- Price
- MVF $7.18
- SGMO $1.09
- Analyst Decision
- MVF
- SGMO Buy
- Analyst Count
- MVF 0
- SGMO 5
- Target Price
- MVF N/A
- SGMO $5.20
- AVG Volume (30 Days)
- MVF 162.8K
- SGMO 10.5M
- Earning Date
- MVF 01-01-0001
- SGMO 03-12-2025
- Dividend Yield
- MVF 4.11%
- SGMO N/A
- EPS Growth
- MVF N/A
- SGMO N/A
- EPS
- MVF N/A
- SGMO N/A
- Revenue
- MVF N/A
- SGMO $52,291,000.00
- Revenue This Year
- MVF N/A
- SGMO N/A
- Revenue Next Year
- MVF N/A
- SGMO $5.97
- P/E Ratio
- MVF N/A
- SGMO N/A
- Revenue Growth
- MVF N/A
- SGMO N/A
- 52 Week Low
- MVF $5.85
- SGMO $0.30
- 52 Week High
- MVF $7.19
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- MVF 48.93
- SGMO 35.59
- Support Level
- MVF $7.14
- SGMO $1.00
- Resistance Level
- MVF $7.26
- SGMO $1.18
- Average True Range (ATR)
- MVF 0.08
- SGMO 0.16
- MACD
- MVF 0.01
- SGMO -0.06
- Stochastic Oscillator
- MVF 77.63
- SGMO 9.89
About MVF Blackrock MuniVest Fund Inc.
Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.